Bausch Health Companies Inc.
- BHC
- NYSE
- Drug Manufacturers - Specialty & Generic
- Pharmaceuticals (Specialty/Generic)
- Ophthalmology
- Medical devices
$6.30
Today −0.16%Quote Oct 16, 2026, 08:00 PM UTC
+11.50%over the last month
Max drawdown −4.2%From 1-month high −0.2%3 months +34.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$2.36B
Quote Oct 16
Next earnings
Oct 28
Expected, not confirmed
Analyst target
$9.00
+42.9% from here
Floor
$6.27
0.5% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BHCPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $2.85B
- Product$2.83B99.1%
- Product and Service, Other$27.0M0.9%
Industry
Drug Manufacturers - Specialty & Generic
Employees
20,300